BDO Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$620K Buy
6,146
+86
+1% +$8.6K 0.07% 158
2023
Q1
$558K Sell
6,060
-453
-7% -$39.6K 0.07% 160
2022
Q4
$591K Buy
6,513
+645
+11% +$54.3K 0.07% 162
2022
Q3
$446K Buy
5,868
+325
+6% +$26.9K 0.06% 177
2022
Q2
$469K Sell
5,543
-149
-3% -$13.1K 0.06% 180
2022
Q1
$499K Sell
5,692
-275
-5% -$23.8K 0.05% 180
2021
Q4
$522K Sell
5,967
-601
-9% -$49.9K 0.06% 180
2021
Q3
$537K Sell
6,568
-657
-9% -$59.1K 0.06% 174
2021
Q2
$659K Buy
7,225
+3,061
+74% +$273K 0.07% 166
2021
Q1
$356K Sell
4,164
-879
-17% -$78.9K 0.04% 212
2020
Q4
$476K Buy
5,043
+38
+0.8% +$3.32K 0.07% 148
2020
Q3
$435K Sell
5,005
-3
-0.1% -$260 0.07% 141
2020
Q2
$437K Buy
5,008
+138
+3% +$11.9K 0.08% 134
2020
Q1
$402K Buy
4,870
+1,049
+27% +$93.6K 0.08% 134
2019
Q4
$362K Buy
3,821
+207
+6% +$18.6K 0.09% 130
2019
Q3
$314K Sell
3,614
-195
-5% -$17.5K 0.08% 150
2019
Q2
$348K Buy
3,809
+498
+15% +$42.1K 0.09% 133
2019
Q1
$285K Buy
3,311
+782
+31% +$62.8K 0.08% 142
2018
Q4
$194K Buy
2,529
+878
+53% +$68.3K 0.07% 152
2018
Q3
$127K Buy
1,651
+112
+7% +$8.28K 0.04% 194
2018
Q2
$104K Buy
1,539
+127
+9% +$8.76K 0.04% 213
2018
Q1
$102K Buy
1,412
+441
+45% +$33.6K 0.04% 184
2017
Q4
$73K Buy
971
+112
+13% +$8.45K 0.03% 177
2017
Q3
$66K Buy
859
+357
+71% +$27K 0.03% 170
2017
Q2
$38K Buy
+502
New +$35.6K 0.02% 255

Other funds holding NVS

BDO Wealth Advisors's NVS Position: Q2 2023 in Review

BDO Wealth Advisors increased its Novartis (NVS) stake by 1.4% in Q2 2023, buying an estimated $8.6K and bringing the position to 6,146 shares worth $620K. The position accounts for 0.07% of the portfolio, ranked #158.

BDO Wealth Advisors first reported a position in NVS in Q2 2017 and has held it in 25 quarters since. The position peaked at $659K in Q2 2021. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • BDO Wealth Advisors held 6,146 shares of Novartis worth $620K as of Q2 2023.
  • BDO Wealth Advisors bought 86 Novartis shares in Q2 2023, an estimated $8.6K.
  • Novartis made up 0.07% of BDO Wealth Advisors's portfolio in Q2 2023, its #158 holding.
  • BDO Wealth Advisors first reported a position in Novartis in Q2 2017 and has held it in 25 quarters since.
  • BDO Wealth Advisors's Novartis position peaked at $659K in Q2 2021.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.